Northrop Grumman Corporation
NOC
$521.50
-5.21%
Northrop Grumman Corporation is a premier global aerospace and defense technology company, providing advanced systems and products across aeronautics, defense, mission, and space segments. As a top-tier U.S. defense contractor, the company is distinguished by its role as a prime integrator on critical national security platforms, including the B-21 Raider stealth bomber, the F-35 fuselage, and a range of space systems and missile defense technologies. The current investor narrative is dominated by heightened geopolitical tensions and a strategic U.S. defense pivot towards AI and autonomous systems, which is driving significant attention to the company's long-term growth prospects and its positioning within rapidly evolving supply chain and technology priorities.…
NOC
Northrop Grumman Corporation
$521.50
Related headlines
Investment Opinion: Should I buy NOC Today?
Rating & Thesis: Hold. NOC is a high-quality defense prime contractor with strong long-term fundamentals, but its current valuation and severe technical breakdown warrant caution, suggesting investors wait for a better entry point or clearer signs of a bottom. This aligns with a neutral stance, acknowledging the 22.6% implied upside to analyst targets but balancing it against significant near-term headwinds.
Supporting Evidence: The stock trades at a forward P/E of 18.26x, a premium to the sector, while revenue growth is solid at 9.6% YoY. Profitability is robust, with net margin expanding to 12.18% in Q4 and strong TTM FCF of $3.31 billion. However, the technical picture is severely damaged, with the stock down 25% in three months and showing negative relative strength of -37% vs. the S&P 500. The implied analyst target of ~$675 offers attractive upside, but the path to get there is clouded by the current downtrend.
Risks & Conditions: The two biggest risks are 1) continued multiple compression if growth decelerates, and 2) a break below key technical support at the 52-week low of $481. This Hold rating would upgrade to a Buy if the stock stabilizes above $600, signaling a technical reversal, or if the forward P/E compresses to 16x or below on sustained earnings growth. It would downgrade to a Sell if quarterly revenue growth falls below 5% or if net margins contract sequentially. Relative to its history and peers, the stock is fairly valued to slightly overvalued, pricing in its premium positioning but leaving little margin for error.
Sign up to view all
NOC 12-Month Price Forecast
The outlook for NOC is a battle between strong, cash-generative fundamentals and a damaged technical/valuation picture. The base case of a gradual recovery to the $600-$675 range is most probable, assuming execution remains on track. The stance is neutral due to the high uncertainty around the timing of a technical bottom. Confidence is medium because while the fundamental story is intact, the stock's recent behavior (negative beta) suggests it is trading on sentiment disconnected from the broader market. The stance would turn bullish on a confirmed technical reversal above $600 or a valuation drop below a 16x forward P/E. It would turn bearish on a breakdown below the $481 support or a material deterioration in quarterly margins.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Northrop Grumman Corporation's 12-month outlook, with a consensus price target around $677.95 and implied upside of +30.0% versus the current price.
Average Target
$677.95
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$417 - $678
Analyst target range
Analyst coverage is limited but positive, with 8 analysts providing estimates and recent institutional ratings showing a strong bullish bias, including multiple 'Buy' or 'Outperform' actions from firms like UBS, Citigroup, and RBC Capital in January 2026. The consensus average target price is not explicitly provided in the data, but the estimated EPS average for the forward period is $36.95, which, when combined with the forward PE of 18.26x, implies a potential price target around $675, suggesting significant upside from the current $550.33 price if those earnings estimates are met. The target range, inferred from estimated EPS, shows a high of $37.70 and a low of $36.37, indicating a relatively tight spread and high conviction among analysts regarding near-term financial performance, with the high target likely pricing in successful execution on key programs like the B-21 and benefits from increased defense budgets, while the low target may reflect concerns over supply chain challenges or program execution risks.
Bulls vs Bears: NOC Investment Factors
The bull case, supported by strong fundamentals, geopolitical catalysts, and analyst conviction, currently holds stronger evidence for the long-term investor. However, the bear case presents a powerful near-term technical and sentiment-driven overhang. The most critical tension in the investment debate is whether the stock's sharp 25% three-month decline represents a buying opportunity in a high-quality defense name or the beginning of a sustained derating as its premium valuation (19.57x trailing P/E) converges with historical and sector norms. The resolution hinges on whether upcoming earnings can demonstrate that margin expansion and revenue growth can offset the multiple compression risk evident in the severe technical breakdown.
Bullish
- Strong Backlog & Geopolitical Tailwinds: As a prime contractor on critical national security platforms like the B-21 Raider and F-35, NOC benefits from a multi-decade, non-discretionary revenue backlog. Recent news highlights escalating U.S.-Iran tensions, which historically drive increased defense spending and investor rotation into defense stocks, providing a near-term catalyst.
- Robust Profitability & Margin Expansion: Q4 2025 net margin expanded to 12.18%, up significantly from 5.08% in Q1 2025, demonstrating strong operating leverage as revenue scaled. The company also generated substantial TTM free cash flow of $3.31 billion, supporting shareholder returns and strategic investments without external financing needs.
- Analyst Conviction & Significant Upside: Analyst sentiment is strongly bullish, with recent 'Buy' or 'Outperform' ratings from major firms. Using the forward EPS estimate of $36.95 and a forward P/E of 18.26x, the implied price target is approximately $675, representing a 22.6% upside from the current price of $550.33.
- Solid Revenue Growth Trajectory: Q4 2025 revenue grew 9.6% year-over-year to $11.71 billion, with sequential quarterly revenue accelerating from $9.47B in Q1 to $11.71B in Q4. This indicates strong execution and demand across its key Aeronautics, Mission, and Space segments.
Bearish
- Severe Technical Downtrend & Weak Momentum: The stock is in a pronounced downtrend, down 24.99% over three months and trading at just 71% of its 52-week range. Negative momentum is confirmed by a -0.27% one-month return and a stark -36.99% three-month relative strength versus the S&P 500, indicating heavy institutional selling.
- Elevated Valuation vs. History & Peers: The trailing P/E of 19.57x is above its historical 5-year average (typically 14x-18x) and above the typical Industrials/Aerospace & Defense sector range. This suggests elevated growth expectations are already priced in, leaving limited room for multiple expansion and increasing vulnerability to compression.
- High Leverage and Low Gross Margins: A debt-to-equity ratio of 1.18 indicates moderate but meaningful leverage. The capital-intensive business model is reflected in a Q4 gross margin of 19.6%, which pressures overall profitability and exposes the company to inflation and supply chain cost pressures.
- Negative Beta Signals Idiosyncratic Risk: A beta of -0.121 indicates the stock has recently moved inversely to the broader market, decoupling from the S&P 500's 12% three-month gain. This unusual correlation suggests company-specific issues are driving price action, adding unpredictable volatility and reducing its utility as a portfolio diversifier.
NOC Technical Analysis
The stock is in a pronounced downtrend from its recent highs, having declined 24.99% over the past three months and currently trading at $550.33, which is approximately 71% of its 52-week range ($481.28 to $774.00). This positioning near the lower end of the annual range suggests the stock is approaching a potential value zone, though the steep decline indicates significant selling pressure and a breakdown from its previous uptrend. Recent momentum is decisively negative, with the stock down 0.27% over the past month and down 24.99% over three months, a sharp reversal from its positive 10.70% one-year performance; this divergence signals a significant trend change, likely driven by profit-taking or a reassessment of near-term growth expectations, exacerbated by a negative beta of -0.121 indicating unusual, low-correlation volatility. Key technical support is the 52-week low of $481.28, while resistance is the recent high of $774.00; a sustained break below support could trigger further declines toward the $450 area, whereas a recovery above the $600 level would be needed to signal a trend reversal, with the stock's negative beta highlighting its recent decoupling from broader market movements, which adds idiosyncratic risk.
Beta
-0.12
-0.12x market volatility
Max Drawdown
-32.1%
Largest decline past year
52-Week Range
$481-$774
Price range past year
Annual Return
+5.4%
Cumulative gain past year
| Period | NOC Return | S&P 500 |
|---|---|---|
| 1m | -6.3% | +1.8% |
| 3m | -26.2% | +15.1% |
| 6m | -8.3% | +9.7% |
| 1y | +5.4% | +25.0% |
| ytd | -11.0% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NOC Fundamental Analysis
Revenue growth is solid but decelerating from a high base, with Q4 2025 revenue of $11.71 billion representing a 9.6% year-over-year increase; however, sequential quarterly revenue from Q1 to Q4 2025 shows a pattern of $9.47B, $10.35B, $10.42B, and $11.71B, indicating accelerating growth into year-end, driven by strong performance across all segments, particularly Aeronautics Systems at $3.92 billion and Mission Systems at $3.45 billion. The company is highly profitable, with Q4 2025 net income of $1.43 billion and a net margin of 12.18%, though gross margin of 19.6% reflects the capital-intensive nature of the business; profitability has improved sequentially from a net margin of 5.08% in Q1 to 12.18% in Q4, demonstrating significant operating leverage and margin expansion as revenue scaled. Financial health is robust, with a debt-to-equity ratio of 1.18 indicating moderate leverage, a strong return on equity of 25.08%, and substantial free cash flow generation of $3.31 billion (TTM), providing ample internal funding for dividends, share repurchases, and strategic investments without reliance on external financing.
Quarterly Revenue
$11.7B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.19%
Latest Quarter
Free Cash Flow
$3.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NOC Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 19.57x and a forward PE of 18.26x; the modest discount of the forward multiple suggests the market anticipates only slight earnings growth or potential margin stabilization in the near term. Compared to sector averages, NOC's trailing PE of 19.57x is slightly above the typical Industrials/Aerospace & Defense range, often in the mid-teens, indicating a modest premium that may be justified by its prime contractor status, strong backlog visibility, and exposure to high-priority defense spending areas like space and missile defense. Historically, the current trailing PE of 19.57x is above its own 5-year average, which has often fluctuated between 14x and 18x based on the provided historical data, suggesting the stock is trading at the higher end of its historical valuation band, which could imply elevated expectations are already priced in following its recent rally, leaving limited room for multiple expansion.
PE
19.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -33x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Northrop Grumman's financial risks are moderate but notable. The company carries a debt-to-equity ratio of 1.18, which, while manageable given its strong cash flow, increases interest expense sensitivity in a higher-rate environment. The business model is capital-intensive, evidenced by a Q4 gross margin of 19.6%, leaving it vulnerable to inflation in labor and materials, which could compress profitability if not passed through to government contracts. Furthermore, revenue, while growing, is heavily concentrated in U.S. defense spending, creating dependency on political budget cycles and specific program funding.
Market & Competitive Risks: The primary market risk is valuation compression. Trading at a trailing P/E of 19.57x, above its historical range and the sector median, the stock is priced for perfection. Any earnings disappointment or sector rotation away from defense could trigger significant multiple contraction. The stock's negative beta of -0.121 indicates it is currently driven by idiosyncratic factors, not broader market trends, adding unpredictable volatility. Competitive risks include new entrants in space and AI (e.g., SpaceX, Rocket Lab) and the ongoing, costly need to reshore rare earth supply chains away from China, as highlighted in recent news.
Worst-Case Scenario: A worst-case scenario involves a perfect storm of program execution issues on the B-21 or F-35, combined with a unexpected downturn in the defense budget cycle and a broader market sell-off compressing valuations. This could trigger analyst downgrades and a flight to safety. The realistic downside is anchored by the 52-week low of $481.28, which represents a potential 12.6% decline from the current price of $550.33. A more severe bear case, factoring in a reversion to the lower end of its historical P/E range (14x), could see the stock fall towards $500, implying a ~9% loss. The maximum drawdown of -31.5% serves as a historical reminder of the stock's volatility during stress periods.
FAQ
The key risks are, in order of severity: 1) Valuation Compression: Trading at a premium P/E (19.57x), the stock is vulnerable to multiple contraction if growth disappoints. 2) Execution & Program Risk: Cost overruns or delays on major programs like the B-21 could hurt margins and sentiment. 3) Geopolitical & Budgetary Risk: While currently a tailwind, an unexpected de-escalation or U.S. budget deficit pressures could slow defense spending growth. 4) Technical & Sentiment Risk: The severe 3-month downtrend (-25%) and negative beta (-0.121) indicate weak momentum and idiosyncratic selling pressure that could persist irrespective of fundamentals.
The 12-month forecast presents three scenarios. The Base Case (50% probability) targets $600-$675, assuming the company meets analyst EPS estimates of $36.95 and the stock's valuation stabilizes. The Bull Case (30% probability) targets $675-$774, driven by stronger-than-expected defense budgets and successful program execution. The Bear Case (20% probability) targets $481-$550, where valuation compresses further and the stock tests its 52-week low. The most likely scenario is the Base Case, anchored by the analyst-implied target of ~$675, but the path is contingent on the stock finding a technical bottom after its sharp decline.
NOC is fairly valued to slightly overvalued relative to its own history, but its premium may be justified by its unique positioning. The trailing P/E of 19.57x is above its 5-year historical average (typically 14x-18x) and above the typical Aerospace & Defense sector range. The forward P/E of 18.26x suggests the market expects only modest earnings growth. This valuation implies the market is paying a premium for NOC's prime contractor status, backlog visibility, and exposure to high-priority spending areas like space. Therefore, the stock is not deeply undervalued; it is priced for steady execution, leaving little room for error.
NOC presents a complex risk/reward profile. For long-term investors, the 22.6% upside to the analyst-implied target of ~$675 is attractive, supported by strong fundamentals like a 12.18% net margin and $3.31B in annual free cash flow. However, the stock is in a severe technical downtrend, down 25% in three months, and trades at a forward P/E of 18.26x, which is above its historical average. The biggest downside risk is a further valuation compression if growth slows. It is a good buy for patient investors who can withstand volatility and are seeking a defense anchor for their portfolio, but tactical investors should wait for a confirmed technical bottom, likely above $600.
NOC is far more suitable for a long-term investment horizon (3-5 years minimum). Its business model is based on multi-decade government contracts, providing earnings visibility that benefits patient investors. The stock's recent high volatility (negative beta, -31.5% max drawdown) and lack of a strong dividend (1.58% yield) make it a poor candidate for short-term trading. The current technical weakness suggests short-term traders could face further downside. Long-term investors can look through the volatility to capture the structural growth in defense and space spending, and the company's strong free cash flow supports consistent capital returns over time.